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Abstract
Causal inference often relies on the counterfactual framework,
which requires that treatment assignment is independent of
the outcome, known as strong ignorability. Approaches to
enforcing strong ignorability in causal analyses of observa-
tional data include weighting and matching methods. Effect
estimates, such as the average treatment effect (ATE), are then
estimated as expectations under the reweighted or matched
distribution, P . The choice of P is important and can impact
the interpretation of the effect estimate and the variance of
effect estimates. In this work, instead of specifying P , we
learn a distribution that simultaneously maximizes coverage
and minimizes variance of ATE estimates. In order to learn
this distribution, this research proposes a generative adver-
sarial network (GAN)-based model called the Counterfactual
χ-GAN (cGAN), which also learns feature-balancing weights
and supports unbiased causal estimation in the absence of
unobserved confounding. Our model minimizes the Pearson
χ2-divergence, which we show simultaneously maximizes
coverage and minimizes the variance of importance sampling
estimates. To our knowledge, this is the first such application
of the Pearson χ2-divergence. We demonstrate the effective-
ness of cGAN in achieving feature balance relative to estab-
lished weighting methods in simulation and with real-world
medical data.
Introduction
Causal assessment often relies on the framework of coun-
terfactual inference. In this framework, each unit, i, has a
potential outcome given that they received a treatment and
a potential outcome given that they received a control – Y1,i
and Y0,i, respectively. This framework seeks to contrast the
outcome, Y for an individual under these two hypothetical
states as shown in Eq. 1 (Rubin 1974).
ITE = Y1 − Y0 (1)
The effect of the treatment on the outcome can then summa-
rized by calculating population-level effect estimates, such
as the average treatment effect (ATE), which is defined as the
expected difference in outcomes (Eq. 2).
ATE = E[Y1 − Y0] = E[Y1]− E[Y0] (2)
Copyright c© 2020, Please direct all questions and com-
ments to corresponding author, Amelia J Averitt, at
aja2149@cumc.columbia.edu
Estimating this requires access to the outcome for the state
in which units were not assigned (i.e., E[Y0|T = 1] and
E[Y1|T = 0]). In practice, however, these true counterfactu-
als are never observed as a single population (or individual)
cannot simultaneously be both treated and untreated. This
is known as the ’fundamental problem of causal inference.’
Therefore, approximations that employ more than one popula-
tion are used as a proxy for these unobserved states (Holland
1986). These approximations seek to construct populations
such that the observed ATE, ˆATE, equals the true ATE that
would arise from a counterfactual population. In other words,
we seek an ˆATE that is unbiased.
ˆATE = E[Y1|T = 1]− E[Y0|T = 0] (3)
A decomposition of the ATE, demonstrates that a sufficient
condition for unbiased ˆATE estimation is that E[Y1|T =
1) = E(Y1|T = 0) and E[Y0|T = 0) = E(Y0|T = 1)
(Kempthorne 1955). Within the counterfactual framework,
this equality is central to the assumption of strong ignorability
(Eq. 4) (Rosenbaum and Rubin 1983).
Yi(1), Yi(0) ⊥⊥ Ti (4)
This assumption states a units assignment to a treatment is
independent of that units potential outcomes, Yi, and that
treatment assignment is, therefore, ignorable. Causal claims
borne from data that satisfy this requirement are regarded
as unbiased as all confounding factors that could induce a
dependence between Yi and Ti are equally represented in the
treatment and comparator arms (Rubin 1974). Consequently,
this means that the distribution of features is the same in both
arms and features are said to be balanced. Other assumptions,
such as positivity and the Stable Unit Treatment Value As-
sumption (SUTVA), are also necessary and assumed to be
true (Rubin 1980).
Matching and weighting are popular pre-analysis manip-
ulations to approximate the unconditional form of strong
ignorability in observational populations. These methods
create pseudo-populations in which the assumption is met
without need for further manipulation (Rubin 1973). This
is opposed to methods of statistical adjustment, which oc-
cur peri-analysis, and approximate the conditional form of
strong ignorability (Leger 1994). Arguably, the most common
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strategy for weighting is the inverse probability of treatment
weighting (IPW) (Thoemmes and Ong 2016), though other
methods include the direct minimization of imbalance (Gret-
ton et al. 2009; Kallus 2016; Kallus 2017) or weighting by the
odds of treatment, kernel weighting, and overlap weighting
(Rosenblatt 1956; Hellerstein and Imbens 1999; Hazlett 2016;
Li, Morgan, and Zaslavsky 2018; Kallus 2018b).
A commonality among these methods is that they implic-
itly or explicitly all specify a distribution function, P , that
the expectation in Eq. 2 is taken with respect to. This dis-
tribution is often the distribution associated with the treated
(p1(x)), the controls (p2(x)), or a combination thereof (e.g.
1
2p1(x) +
1
2p2(x)). This choice of distribution can lead to
high variance effect estimates in circumstances where there
are regions of poor overlapping support between the treated
and untreated populations. An effect of this is often observed
in the context of IPW analyses with instability due to propen-
sity scores near zero or one. (Kang and Schafer 2007).
In this work, we instead construct an implicit distribution,
P , that focuses on the regions of the sample space with signif-
icant overlap between the treated and untreated populations.
Such a construction involves an inherent trade-off between
coverage and variance. For example, mixture distributions
that will be valid for a larger region of the sample space will
also produce high variance estimates in the context of a fixed
sample budget. In the context of infinite sample sizes and
positivity, one could specify any distribution P without con-
cern for effect estimate variance. The mixture distribution of
the treated and untreated populations would be a reasonable
choice given a goal of maximizing coverage. However, in
real-world settings with limited data, positivity may not be
present and ATE estimates over such a distribution may be
high variance in practice and theoretically invalid. In such
a setting, valid estimates can only be made for subpopula-
tions with significant distributional overlap. We formulate
an approach that constructs a distribution P for estimating
Eq. 2 that both maximizes coverage and minimizes variance.
Informally, P can be considered the distribution of a natural
experiment where the choice of treatment, T , is independent
of potential confounders, X .
We propose the Counterfactual χ-GAN (cGAN) that uses
an adversarial approach to learn a distribution that trades off
coverage and effect estimate variance for two or more ob-
servational study arms. This approach learns stable, feature
balancing weights without reliance on the propensity score.
The target distribution, P , is identified by minimizing the
Pearson χ2-divergence between P and the sampling distribu-
tions Qa for each study arm. To our knowledge, this is the
first such application of the Pearson χ2-divergence. Because
P is being compared to all study arms, this encourages cov-
erage, while, as we will show, the χ-divergence inherently
minimizes the variance of importance sampling estimates of
the ATE.
This paper proceeds as follows: Section 2 defines the
model and learning procedures, Section 3 presents an evalua-
tion of this model through a simulation and an application to
real-world clinical data, and finally, Section 4 discusses open
issues, limitations of the model, and future work.
The Model
We introduce the Counterfactual χ-GAN (cGAN), an adver-
sarial approach to feature balance in causal inference that is
based on importance sampling theory. Using an adversarial
approach based on variational minimization based on the
f -GAN, we minimize the sum of the Pearson χ2-divergences
between a deep generative model and the sampling distribu-
tions from each arm of a study. We show that minimizing
the χ2-divergence is equivalent, up to a constant factor, to
minimizing the variance of importance sampling estimates
to be made in approximating quantities such as ATEs. Sim-
ilar to other weighting approaches, this approach assumes
SUTVA, positivity, and no unmeasured confounders. In the
following, P is the constructed target distribution and Qa is
the sampling distribution for each study arm.
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Figure 1: Architecture of Counterfactual χ-GAN
Importance Sampling and the χ2-divergence Impor-
tance sampling is a strategy for estimating expectations under
an unknown target distribution given a known proposal dis-
tribution (Muller 1966). Though the importance sampling
has broader usage than our application, we focused on the
use of importance sampling for estimation of the average
treatment effect (ATE) because of its close relationship with
the χ2 divergence. The importance sampling weight is de-
fined as a likelihood ratio: the likelihood of an observation
under the target distribution, p(x) divided by the likelihood
under the proposal distribution, q(x). Weighted expectations
based on the proposal distribution approximate unweighted
expectations from the target distribution at shown in Eq. 5.
Eq
[
p(x)
q(x)
φ(x)
]
= Ep [φ(x)] (5)
Consider the units in an arm of an observational study as be-
ing samples from such a proposal distribution. One strategy
for obtaining unbiased expectations of treatment effects is
to identify importance sampling weights for each arm that
approximate expectations from a shared target distribution.
However, this problem is underspecified given that we could
choose any target distribution with the correct support. In this
work, we choose the target distribution that yields importance
sampling approximations with smallest variance. Eq. 6 shows
the form for the variance of importance sampling estimates
where φ(x) is the constant function. This choice is to make
the formulation of the cGAN as outcome agnostic as possible.
This form highlights its connection with the χ2-divergence,
which has a function form as shown in Eq. 7. This connec-
tion was previously noted in (Dieng et al. 2017). Therefore,
the solution which minimizes the χ2-divergence would also
minimize the variance expectations for unknown outcomes.
Of note, importance sampling is known to be a method that
can produce high variance estimates, but since we will be
minimizing the variance directly, this is less of a concern
here.
σ2q =
µ2
n
(∫
q(x)
[
p(x)2
q(x)2
− 1
])
dx (6)
χ2(p ‖ q) =
∫
q(x)
[
p(x)2
q(x)2
− 1
]
dx (7)
Likelihood Ratio ATE Estimation Consider two distribu-
tions Q1 and Q2 that represent two arms of a study. It is
possible to make unbiased ATE estimates based on a sin-
gle distribution, P , leveraging likelihood ratios/importance
sampling weights as shown in Eq. 8.
ATE = Ep[Y1]−Ep[Y0] = Eq1
[
p(x)
q1(x)
Y1
]
−Eq2
[
p(x)
q2(x)
Y0
]
(8)
We will leverage an approach based on adversarial learning
to simultaneously minimize the variance defined in Eq. 6 and
directly estimate likelihood ratios, p(x)q1(x) and
p(x)
q2(x)
.
f -GAN The f -GAN framework provides a strategy for
estimation and minimization of arbitrary f -divergences based
on a variational divergence minimization approach (Nowozin,
Cseke, and Tomioka 2016).
Df (P ‖ Q) =
∫
X
q(x) sup
t∈domf∗
{
t
p(x)
q(x)
− f∗(t)
}
dx (9)
≥ sup
T∈T
(∫
X
p(x)T (x)dx−
∫
X
q(x)f∗(T (x))dx
)
(10)
= sup
T∈T
(Ex∼P [T (x)]− Ex∼Q[f∗(T (x))]) (11)
where T is a class of function such that T : X → R, f is
the function that characterizes the χ2-divergence, f(u) =
(u− 1)2, f∗ is the Fenchel conjugate of f , f∗(t) = 14 t2 + t,
and P and Q are probability distributions with continuous
densities, p(x) and q(x). T is typically a multi-layer neural
network. This formulation lower bounds the χ2-divergence
based on functions T , P , and Q in such a way that unbiased
noisy gradients of the lower bound can be easily obtained
based on samples from P and Q. In addition, the variational
function, T , has a tight bound for T ∗ = f ′
(
p(x)
q(x)
)
which is
equivalent to 2
(
p(x)
q(x) − 1
)
in the case of the χ2-divergence.
To respect the bounds of T that result in valid likelihood
ratios, we represent T as a nonlinear transformation of an
unbounded function V : T (x) = gf (V (x)) = −2 + log(1 +
eV (x)). The likelihood ratio, pq , is easily derived from here
and provides the importance sampling weights necessary for
approximating expectations under p(x) as shown in Eq. 5.
The Counterfactual χ-GAN The cGAN builds on impor-
tance sampling theory and extends the f -GAN framework
to learn feature balancing weights through an adversarial
training process. Previously, (Tao et al. 2018) have explored
importance weights from critics of divergence-based GAN
models. However, unlike this method and other f -GANs
where there is a generator,G and a single variational function,
the cGAN employs dual training from at least two variational
functions (Figure 1).
Consider a set ofA treatments, each associated with one of
A populations, or arms of a study. Each population contains
Na units and are drawn from an unknown and population-
specific distribution Qa. Based on the connection between
the χ2-divergence and the variance of importance sampling
estimates outlined above, our objective is to identify a target
distribution that minimizes the χ2-divergence to all popu-
lations being compared: argminp
∑A
a=1 χ
2 (p(x) ‖ qa(x)).
This is the sum of the divergences between the generator and
the unweighted treatment arms. It is minimized when p(x)
equals qa(x) for all a and is directly proportional to the sum
of the variances of importance sampling estimates under the
target distribution, P , with proposals, Qa. Because of the
constant in Eq. 6, minimizing the χ2-divergence is equiva-
lent to minimizing a normalized variance which weighs each
population equally regardless of the number of units and the
magnitude of the treatment effect, φ.
As a byproduct of minimizing this divergence, we will
also identify a set of importance weights, wa,n, for each
unit in each population that allows estimation of expecta-
tions from the same target distribution, P , thus satisfying
the unconditional form of strong ignorability. Using these
importance weights, expectations can be approximated as
Ep[f ] ≈
∑Na
n=1 waφ(xa,n) where wa,n =
1
c
p(xa,n)
qa(xa,n)
, where
c =
∑Na
n=1
p(xn)
qa(xn)
is an normalizing constant, p is the den-
sity of the shared target distribution, qa is the density of the
proposal distribution, and xa,n ∼ Qa. Note that our strat-
egy eliminates the need to explicitly evaluate p (xa,n) and
qa(xa,n) as the likelihood ratio is estimated directly by the
f -GAN. If desired, expectations can also be approximated
using the sample-importance-resampling (SIR) algorithm
where samples approximately distributed according to p can
be simulated by drawing samples from the weighted empiri-
cal distribution qˆa(x) = 1Na
∑Na
n=1 wa,nδ(x−xa,n) (Doucet,
Freitas, and Gordon 2001).
The objective function for the cGAN is shown in Eq. 12
and is closely related to the objective defined in (Nowozin,
Cseke, and Tomioka 2016). θ parameterizes the generative
model and ωa parameterizes the variational model for each
treatment arm, a. In our experiments, Vωa for all a are neural
networks that mirror discriminators in the traditional GAN
framework and Pθ is a neural networks that mirrors the gen-
Algorithm 1: Minibatch stochastic gradient cGAN opti-
mization
Input :(x1,1,...,x1,N1 ,...,xA,NA)
Output :θ, ω1:A
Initialize θ, ω1:A and minibatch size, M .
while F (θ, ω1:A) not converged do
for a ∈ (1, . . . , A) treatment groups do
Sample a batch of noise samples, z1:M ∼ pg ,
where pg is a prior distribution such as an
isotropic Gaussian
Sample minibatch of data, xa,1:M ∼ qa
Compute gradient w.r.t. variational function
parameters
∇ωaF =
∑M
m=1∇ωa(gf (Vωa(Gθ(zm)))−
1
4gf (Vωa(xa,m))
2 − gf (Vωa(xa,m)))
Ascend the ωa gradient according to a
gradient-based optimizer
end
Compute gradient w.r.t. generator parameters
∇θF =
∑M
m=1
∑A
a=1∇θ [gf (Vωa(Gθ(zm)))]
Descend the θ gradient according to a gradient-based
optimizer
Update Vωa and Gθ learning rates according to
schedule
end
erator. Note that the generator in the original f -GAN frame-
work is usually Qa. In our case, to achieve the desired di-
rectionality of the χ2-divergence, the empirical distribution
must be Qa and the generator must be P .
F (θ, ω1:A) =
A∑
t=1
(
Ex∼Pθ
[
gf (Vωt(x))
]
+
Ex∼Qa
[− 1
4
gf (Vωa(x))
2 − gf (Vωa(x))
])
(12)
Importance weights can be computed based on the fact
that the bound in Eq. 11 is tight for T ∗(x) = f ′
(
p(x)
q(x)
)
where f(u) = (u − 1)2. We can therefore, approximate
the desired importance weights as described in Eq. 5 as
wa,n =
gf (Vωa (xa,n))
2 + 1 for all a ∈ (1, . . . , A) and
n ∈ (1, . . . , Na). Ultimately, the ATE can be estimated be-
tween any two treatment arms according to Eq. 8. For exam-
ple, the ATE between arms 1 and 2 could be estimated as
ˆATE =
∑N1
n=1 [w1,nY1,n]−
∑N2
n=1 [w2,nY2,n].
Practical Considerations In the original GAN and f -
GAN formulations the gradients for the generator is replaced
with a related gradient that significantly speeds convergence
of the model. Because our objective is minimization of the
true χ2-divergence rather than perfect distributional match-
ing, we do not employ this loss function trick but instead
apply the gradient as derived from the loss function in Eq.
12.
Although it is the case that the domain of the Fenchel
conjugate for the χ2-divergence is R, we constrained it to
t ≥ −2 which produces valid likelihood ratios.
Gradient descent-based optimization of GANs is a not-
edly difficult task (Mescheder, Geiger, and Nowozin 2018;
Arjovsky and Bottou 2017; Gulrajani et al. 2017). Though
many methods are proposed to stabilize training, we have
found it sufficient to employ a set of algorithmic heuristics:
(i) standardization of our data by the joint mean and variance
over all A populations prior to training; (ii) periodically re-
centering the distribution of each discriminator to a noisy
estimate of the mean of the generator distribution. This re-
centering is accomplished by setting the value of a vector
that is added to the input of the discriminators.
The approach for minibatch stochastic gradient descent for
the cGAN is shown in Algorithm 1. The objective function
F (Eq. 12) is optimized by minimizing with respect to the
parameters θ of the generator and maximizing with respect
to the parameters ω1:A of the discriminators.
Related Work Causal inference with observational data
has a rich literature that cuts across many disciplines (Thrus-
field 2017; Rubin 1973; Rubin 1974; Pearl 2000) includ-
ing machine learning (Johansson, Shalit, and Sontag 2016;
Kallus 2018a; Shalit, Johansson, and Sontag 2017; Ratkovic
2014; Schwab, Linhardt, and Karlen 2018). More specifi-
cally there have been several approaches to applying adver-
sarial networks for counterfactual inference (Kallus 2018a;
Yoon, Jordon, and van der Schaar 2018). However, most ex-
isting methods for counterfactual inference are not directly
comparable to the cGAN, as we aim to identify the most
appropriate counterfactual distribution given the available
data and maximize feature balance whereas most methods
evaluate ATE estimation or ITE estimation directly.
In contrast to representational learning approaches and
some GAN approaches, our approach does not rely on a pre-
defined outcome to identify matched cohorts. The approach
outlined in (Kallus 2018a) is the most similar in spirit to our
approach but differs in that our objective directly minimizes
the variance of expectations that might be used in ATE esti-
mation, whereas (Kallus 2018a) minimizes a bound on the
variance of the average treatment effect on the treated. As
a result, there is no need for a regularizer, to perform cross-
validation to select an appropriate level of regularization, or
perform a constrained optimization over weights.
Experiments
To evaluate the cGAN, including its utility in practice, we
present results of a simulation and applications to real-world
medical data.
Simulation
To evaluate the cGAN when the ground truth is known,
we applied the model on simulated data of two popula-
tions/treatment arms, A = 2. Each population was com-
prised of two subpopulations. Each subpopulation contained
10 features, drawn from a randomly generated multivariate
normal distribution with a normal-Wishart prior distribution.
Population 1 was composed of an equal number of samples
(N=1000) from subpopulation A and subpopulation B; and
Population 2 was composed of an equal number of sam-
ples from subpopulation A and subpopulation C (N=2000).
By construction, subpopulation A is a latent population as-
sociated with a natural experiment, since it is part of both
Population 1 and 2.
Because our simulation deliberately constructs populations
from a shared subpopulation distribution (A), we would ex-
pect points generated from this subpopulation to have higher
weights. Intuitively, the variance of importance sampling es-
timates should be small for both treatment groups (a = 1
and a = 2) if the learned target distribution, Pθ is one that
overlaps both populations maximally while excluding density
unique to one group.
To better demonstrate how the cGAN supports counterfac-
tual reasoning, we have additionally conducted an analysis of
the average treatment effect (ATE) for our experiment with
simulated data. We simulated a continuous outcome accord-
ing to the subpopulation of origin – Pop 1A ∼ Gaussian (60,
1); Pop 1B ∼ Gaussian (40, 1); Pop 2A ∼ Gaussian (-10, 1);
Pop 2C ∼ Gaussian (10, 1). Under this outcome function, the
estimate of average treatment effect (ATE) under the mixture
distribution (of Pop 1 and Pop 2) is 50. When estimating
the ATE under the overlapping subpopulation distribution –
those from Pop 1A and Pop 2A – the ATE is 70. We applied
weights from the cGAN and comparators to the simulated
outcomes to assess the ability of the weighting methods to
estimate one of the two ATEs. In addition, we also calculated
the effective sample size (ESS), neff , using the Kish Method
(Kish 1965). The ESS may be used to determine the quality
of a Monte Carlo approximations of importance sampling.
The calculation of neff can be found in the equation below,
wherein w are the weights.
neff =
(
∑n
i=1 wi)
2∑n
i=1 w
2
i
To investigate (i) feature-balancing weights, (ii) the biased-
ness of ATE, and (iii) the ESS, a variety of comparator meth-
ods were implemented in addition to the cGAN . They include
binary regression propensity score; generalized boosted mod-
eling of propensity scores (McCaffrey, Ridgeway, and Mor-
ral 2004); covariate-balancing propensity scores (Imai and
Ratkovic 2013); non-parametric covariate-balancing propen-
sity scores (Fong, Hazlett, and Imai 2018); entropy balancing
weights (Hainmueller 2011); empirical balancing calibration
weights (Chan, Yam, and Zhang 2016); optimization-based
weights (Keele and Zubizarreta 2014).
Results The results of our simulation is summarized in
Figures 2. In the left hand-side of the Figure, the columns
show the marginals of three pairs of continuous features. Row
(i) shows the raw data, colored by which population units
were drawn from. Row (ii) shows the same data as above, but
coloring by subpopulation to highlight the overlapping distri-
bution. Row (iii) shows a set of samples from the generator
after training colored in blue. Row (iv) depicts the original
data from Row (i) with the opacity of data points reflecting
the importance weights. The right-hand side of the Figure
shows the distribution of weights by subpopulation. Note that,
in both Populations 1 and 2, the mean weights of units from
subpopulation A have weights near 5x10−4, which is the uni-
form weight when 2000 units are in each population. Units
from other subpopulations have near negligible weights, and
would not meaningfully contribute to expectations in 8.
Subpopulation Mean Weight
1A 4.997x10−4
2B 2.557x10−7
2A 4.992x10−4
2C 7.863x10−7
Table 1: Results of Application to Simulated Data. Mean
cGAN-weight by subpopulation.
In the left-most figure, as you move down any column
of feature pairs, it is apparent that points from the overlap-
ping subpopulation A are both captured by the generator and
assigned higher weights. This is confirmed by plotting the
weights of data points by subpopulation (right-hand side of
2). Weights from subpopulations 1A and 2A are substantially
higher than those from subpopulations 1B and 2C.
The results of this simulation further demonstrate that
the ATE estimate from cGAN-weighted data is less biased
than estimates from other weighting methods, given their
respective targets. By construction, the causal effect of the
comparable subpopulations is 70. cGAN-weighted data pro-
duced an ATE of 70.01. We see similarly good performance
when inspecting the ESS. The cGAN has an ESS of 3870.
Given that there are 4000 units that are comparable across
the two arms (each subpopulation contains 2000 units), this
is an appropriate estimate (Table 2).
Weighting Method ATE ESS
unweighted 50.03 8000
IPW 92.00 6551
clipped IPW 87.24 6997
binary regression PS 92.00 6551
generalized boosted modeling PS 84.51 7207
covariate balancing PS 91.83 6686
non-parametric covariate balancing PS 37.65 11
entropy balancing 104.13 65
empirical balancing calibration weights 52.06 65
optimization-based weights 52.07 114
cGAN 70.01 3870
Table 2: Results of Simulation. The average treatment effect
and effective sample size (ESS) after application of weighting
methods from the Counterfactual χ-GAN and comparators.
Clinical Data
We additionally applied the cGAN to an experiments using
real-world clinical data from a large, academic medical cen-
ter. For this experiment, we constructed the treatment and
Figure 2: Simulation Results. Left: Select features (i) by population of origin; (ii) with subpopulation A highlighted; (iii) samples
from the generator; (iv) opacity adjusted by weight. Right: Weights by subpopulation
comparator cohorts according to the protocol and indication
of a published randomized clinical trial. The experiment com-
pares sitagliptin and glimepiride in elderly patients with Type
II Diabetes Mellitus (N=144 per arm) (Hartley et al. 2015).
We present the 37 most frequent clinical measurements from
the electronic health record.
We evaluate the ability of the cGAN to improve feature
balance by comparing the Absolute Standardized Difference
of Means (ASDM) between the treatment and comparator co-
horts under different weighting methods. the ASDM is a pop-
ular method of assessing cohort similarity, with a lower met-
ric corresponding to improved feature balance. The ASDM is
presented for the cGAN and the comparator weighting meth-
ods mentioned in the simulation. Under the clipped-IPW
procedure, propensity scores greater than 90th percentile and
less than 10th percentile are assigned to the values of the
percentiles at 90th and 10th, respectively (Cole and Herna´n
2008).
Results The ASDM for the clinical cohorts is presented in
Figure 3. These findings are summarized by the mean ASDM
over all features, under the varying weighting methods in
Table 3. cGAN improved mean ASDM from the unweighted
cohort and improved feature balance the most among all eval-
uated methods. Note that this task is particularly challenging
due to the high dimensionality of the data and small study
size.
The results of this experiment can be found in Figure 3 and
Table 3. They demonstrate that cGAN-weighting achieves
better feature balance than comparator methods.
Weighting Method ASDM
unweighted 0.1103
IPW 0.0876
clipped IPW 0.0631
binary regression PS 0.0625
generalized boosted modeling PS 0.0749
covariate balancing PS 0.0681
non-parametric covariate balancing PS 0.0596
entropy balancing 0.0524
empirical balancing calibration weights 0.0524
optimization-based weights 0.0536
cGAN 0.0364
Table 3: Results of Application to Clinical Data. Absolute
standardized difference of the means (ASDM) of real-world
clinical features after application weighting methods from
the Counterfactual χ-GAN and comparators.
Discussion
In this paper, we introduce the Counterfactual χ-GAN. It is
a deep generative model for feature balance that minimizes
the variance of importance sampling estimates of treatment
effects. We leverage the f -GAN framework for estimating the
χ2-divergence and likelihood ratios necessary for achieving
this.
The experiments presented here suggest that cGAN is an
effective method of learning feature balancing weights to
Figure 3: Absolute standardized difference of the means (ASDM) of real-world clinical features after application weighting
methods from the Counterfactual χ-GAN and comparators.
support counterfactual inference. If we assume that all po-
tentially confounding variables are observed, the superiority
of cGAN in learning balancing weights, suggests that ATE
borne from cGAN-weighted cohorts would be less biased
than those estimates generated from traditional weighting
methods.
The application of the model to real-world EHR data,
demonstrates that this method could provide an alternative
means to causal estimation from observational data when the
assumptions of no unobserved confounding, positivity, and
SUTVA are met. Our experiments suggest that the flexibility
of our framework produces improved feature balance rele-
vant for valid causal estimates. This method does, however,
come with limitations. Training of the model is completed
via backpropogation. As such, this method is only suitable
for fully differentiable functions. Therefore, matching based
on a combination of discrete and continuous values poses a
challenge. In addition, GANs are well known for their insta-
bility and lack of objective measures for convergence. This
work shares those limitations. In future work, we will explore
an extension of the cGAN which accommodates discrete data
types and overcome the many current limitations of GANs.
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